Cheshire, United Kingdom

Jon James Gordon Winter


 

Average Co-Inventor Count = 6.2

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Macclesfield, GB (2011)
  • Cheshire, GB (2014)

Company Filing History:


Years Active: 2011-2014

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Jon James Gordon Winter: Innovator in Pharmaceutical Compounds

Introduction

Jon James Gordon Winter, a distinguished inventor based in Cheshire, GB, has made significant contributions to the field of pharmaceuticals. With a total of two patents to his name, Winter’s work focuses on innovative compounds that target critical health issues.

Latest Patents

Winter's most recent patents include advancements in heterocyclic compounds designed as CCR2B antagonists. One notable invention revolves around compounds of the formula (I) Q-L-W—C(—X)—Z—P, featuring pyridine and pyrazine derivatives. This invention specifically discusses the preparation of these compounds and their application in developing pharmaceutical compositions for treating cell proliferative disorders.

Career Highlights

Currently employed at AstraZeneca AB, Jon Winter plays a crucial role in advancing research and development within the pharmaceutical industry. His experience and dedication have contributed to the progress of innovative solutions that address various medical challenges.

Collaborations

Throughout his career, Winter has collaborated with esteemed colleagues such as Justin Fairfield Bower and Bernard Christophe Barlaam. These associations have fostered an environment of creativity and innovation, enhancing the scope and impact of their work in the pharmaceutical field.

Conclusion

Jon James Gordon Winter stands out as a proactive inventor whose work contributes significantly to medical science. His patents reflect a commitment to developing effective therapeutic agents, ultimately improving patient outcomes and advancing the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…